Interleukin-39 as a Potential Biomarker of Diabetic Neuropathy: A Case–Control Study with ROC Curve Analysis
Chemical Interactions · 2026
DOI: 10.64354/n44khb87 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemical Interactions, 2026. Verfasst von Hasan R. Hamood und 3 weiteren Autor:innen. Die Arbeit nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
Diabetic neuropathy is considered the most common prevalent microvascular complication of type 2 diabetes mellitus, manifested by progressive nerve destruction resulting from metabolic and inflammatory mechanisms. The role of IL-39 as a novel pro-inflammatory mediator in diabetic neuropathy has not been clarified yet.
Objective
To assess serum levels of IL-39 and evaluate its clinical diagnostic performance in patients with diabetic neuropathy.
Methods
This case-control study recruited patients with diabetic neuropathy and healthy controls. Metabolic, glycemic, lipid, and insulin resistance parameters were assessed. Diagnostic accuracy assessed by serum levels of IL-39 measuring and ROC curve analysis was conducted.
Results
High IL-39 levels of significance were recorded in diabetic neuropathy patients compared with healthy controls (P < 0.001). The result of ROC curve analysis shows high diagnostic accuracy, indicating strong discriminatory ability
Zitieren
APA
Hamood, H. R., Hamoud, H. R., Al-Tamimi, F. G. T., & Ali, H. A. (2026). Interleukin-39 as a Potential Biomarker of Diabetic Neuropathy: A Case–Control Study with ROC Curve Analysis. Chemical Interactions. https://doi.org/10.64354/n44khb87
Vancouver
Hamood HR, Hamoud HR, Al-Tamimi FGT, Ali HA. Interleukin-39 as a Potential Biomarker of Diabetic Neuropathy: A Case–Control Study with ROC Curve Analysis. Chemical Interactions. 2026. doi:10.64354/n44khb87
BibTeX
@article{Hamood2026,
author = {Hamood, Hasan R. and Hamoud, Hanan R. and Al-Tamimi, Fatima Ghazi Talab and Ali, Hanaa Addai},
title = {Interleukin-39 as a Potential Biomarker of Diabetic Neuropathy: A Case–Control Study with ROC Curve Analysis},
journal = {Chemical Interactions},
year = {2026},
doi = {10.64354/n44khb87}
}
EUVIMED